PROPS

PROPS computes probabilistic pathway scores from gene expression data to produce pathway-level features for supervised disease classification by modeling gene interactions with Bayesian networks and probabilistic graphical models.


Key Features:

  • Probabilistic Pathway Scoring: Aggregates gene expression values into pathway-level scores using probabilistic graphical models.
  • Bayesian Network Representation: Represents biological pathways as Bayesian networks to capture gene interactions and dependencies.
  • Pathway-Based Classification: Produces pathway-centric features that emphasize biological mechanisms rather than individual genes for classification tasks.
  • Robustness Against Noise: Uses aggregated pathway features to reduce sensitivity to noise inherent in individual gene expression measurements.
  • Supervised Machine Learning Integration: Integrates individualized pathway scores into a supervised machine learning framework for disease classification.

Scientific Applications:

  • Disease Differentiation and Prediction: Applied to distinguish ulcerative colitis (UC) from Crohn's disease (CD) using gene expression data.
  • Enhanced Performance in IBD Classification: Outperformed gene-based and alternative pathway-based classifiers across five IBD datasets when classifying CD versus UC.

Methodology:

Represents biological pathways as Bayesian networks (probabilistic graphical models), aggregates gene expression values into individualized pathway scores, and applies supervised machine learning for classification.

Topics

Collections

Details

License:
GPL-2.0
Tool Type:
library
Operating Systems:
Linux, Windows, Mac
Programming Languages:
R
Added:
7/12/2018
Last Updated:
12/10/2018

Operations

Publications

Han L, Maciejewski M, Brockel C, Gordon W, Snapper SB, Korzenik JR, Afzelius L, Altman RB. A probabilistic pathway score (PROPS) for classification with applications to inflammatory bowel disease. Bioinformatics. 2017;34(6):985-993. doi:10.1093/bioinformatics/btx651. PMID:29048458. PMCID:PMC5860179.

PMID: 29048458
PMCID: PMC5860179
Funding: - National Institutes of Health: R01 GM102365, T32 GM007365 and F30 AI124553 - Pfizer Inc.: IC2014-1387

Documentation

Downloads

Links